Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens

被引：56

作者：

Ichimura, T ^{[1
]}

Kawamura, N ^{[1
]}

Ito, F ^{[1
]}

Shibata, S ^{[1
]}

Minakuchi, K ^{[1
]}

Tsujimura, A ^{[1
]}

Umesaki, N ^{[1
]}

Ogita, S ^{[1
]}

机构：

[1] Osaka City Univ, Sch Med, Dept Obstet & Gynecol, Abeno Ku, Osaka 5458585, Japan

来源：

FERTILITY AND STERILITY | 1998年 / 70卷 / 05期

基金：

美国国家卫生研究院;

关键词：

uterine leiomyoma; natural history; estrogen receptor; progesterone receptor; needle biopsy;

D O I：

10.1016/S0015-0282(98)00300-8

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Objective: To examine the relationship between estrogen receptor (ER) and progesterone receptor (PR) content in needle biopsy specimens and the growth of uterine leiomyomata after biopsy. Design: Prospective clinical study. Setting: University teaching hospital. Patient(s): Thirty-one women with uterine leiomyomata and a normal menstrual cycle. Intervention(s): Transcervical needle biopsy of uterine leiomyomata. Main Outcome Measure(s): The relationships between histologic features (smooth muscle content, immunohistochemical expression of ER and PR) and the percent increase over a 12-month observation period in the volume of the largest myoma nodule measured by magnetic resonance imaging were analyzed. Result(s): Both the density and intensity of immunohistochemical staining of PRs in uterine leiomyoma tissue showed significant positive correlation with leiomyoma growth. Conclusion(s): The growth of uterine leiomyomata can be determined by histologic and immunohistochemical analysis of needle biopsy specimens from uterine leiomyomata. (Fertil Steril(R) 1998;70:967-71. (C) 1998 by American Society for Reproductive Medicine.).

引用

页码：967 / 971

页数：5

共 18 条

[1]

Alberts SR, 1996, CANCER-AM CANCER SOC, V78, P764

[2] NUCLEAR ESTROGEN-RECEPTORS IN HUMAN UTERINE ARTERIES [J].

BATRA, S ;

IOSIF, S .

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1987, 24 (04) :250-255

[3] Analysis of the karyotype and desoxyribonucleic acid content of uterine myomas in premenopausal, menopausal, and gonadotropin-releasing hormone agonist-treated females [J].

Brosens, I ;

Johannisson, E ;

DalCin, P ;

Deprest, J ;

VandenBerghe, H .

FERTILITY AND STERILITY, 1996, 66 (03) :376-379

[4]

BUTTRAM VC, 1981, FERTIL STERIL, V36, P433

[5] ESTROGEN AND PROGESTERONE-RECEPTOR CONTENT OF ENUCLEATED UTERINE MYOMATA AFTER LUTEINIZING-HORMONE-RELEASING HORMONE - ANALOG DEPOT THERAPY [J].

CIRKEL, U ;

OCHS, H ;

ROEHL, A ;

SCHNEIDER, HPG .

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1994, 73 (04) :328-332

[6]

FAYED YM, 1989, LAB INVEST, V60, P30

[7] IMMUNOHISTOCHEMICAL ANALYSIS OF ESTROGEN-RECEPTORS, PROGESTERONE RECEPTORS AND KI-67 IN LEIOMYOMA AND MYOMETRIUM DURING THE MENSTRUAL-CYCLE AND PREGNANCY [J].

KAWAGUCHI, K ;

FUJII, S ;

KONISHI, I ;

IWAI, T ;

NABU, Y ;

NONOGAKI, H ;

ISHIKAWA, Y ;

MORI, T .

VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 419 (04) :309-315

[8] Correlation between shrinkage of uterine leiomyoma treated with buserelin acetate and histopathologic findings of biopsy specimen before treatment [J].

Kawamura, N ;

Ito, F ;

Ichimura, T ;

Shibata, S ;

Umesaki, N ;

Ogita, S .

FERTILITY AND STERILITY, 1997, 68 (04) :632-636

[9]

KAWAMURA N, 1996, J GYNECOL TECH, V2, P201

[10]

LAXMAN R, 1993, CANCER, V71, P1283, DOI 10.1002/1097-0142(19930215)71:4<1283::AID-CNCR2820710419>3.0.CO

← 1 2 →